CYP7A1 and metabolic syndrome: This promotes the expression of cholesterol 7α-hydroxylase (CYP7A1) to accelerate cholesterol metabolism and decrease the serum levels of TC, TG, and LDL-C to improve dyslipidemia (Wang Y. et al., 2024).